nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—MTOR—blood vessel—Behcet's disease	0.0508	0.0581	CbGeAlD
Sirolimus—FGF2—eye—Behcet's disease	0.0426	0.0487	CbGeAlD
Sirolimus—EIF4E—nervous system—Behcet's disease	0.0376	0.043	CbGeAlD
Sirolimus—EIF4E—central nervous system—Behcet's disease	0.0362	0.0414	CbGeAlD
Sirolimus—FGF2—mammalian vulva—Behcet's disease	0.0338	0.0386	CbGeAlD
Sirolimus—FGF2—medulla oblongata—Behcet's disease	0.0305	0.0349	CbGeAlD
Sirolimus—EIF4E—brain—Behcet's disease	0.0287	0.0329	CbGeAlD
Sirolimus—FGF2—midbrain—Behcet's disease	0.0279	0.0319	CbGeAlD
Sirolimus—MTOR—brainstem—Behcet's disease	0.0277	0.0317	CbGeAlD
Sirolimus—FGF2—spinal cord—Behcet's disease	0.0272	0.0311	CbGeAlD
Sirolimus—MTOR—eye—Behcet's disease	0.027	0.0309	CbGeAlD
Sirolimus—MTOR—retina—Behcet's disease	0.0268	0.0306	CbGeAlD
Sirolimus—FKBP1A—eye—Behcet's disease	0.0243	0.0278	CbGeAlD
Sirolimus—FKBP1A—retina—Behcet's disease	0.0241	0.0275	CbGeAlD
Sirolimus—MTOR—skin of body—Behcet's disease	0.0235	0.0269	CbGeAlD
Sirolimus—SLC47A1—brainstem—Behcet's disease	0.0214	0.0245	CbGeAlD
Sirolimus—MTOR—mammalian vulva—Behcet's disease	0.0214	0.0245	CbGeAlD
Sirolimus—FKBP1A—skin of body—Behcet's disease	0.0211	0.0242	CbGeAlD
Sirolimus—SLC47A1—eye—Behcet's disease	0.0209	0.0239	CbGeAlD
Sirolimus—FKBP1A—mammalian vulva—Behcet's disease	0.0193	0.0221	CbGeAlD
Sirolimus—FKBP1A—cardiac atrium—Behcet's disease	0.0185	0.0211	CbGeAlD
Sirolimus—FGF2—brain—Behcet's disease	0.0175	0.02	CbGeAlD
Sirolimus—FKBP1A—medulla oblongata—Behcet's disease	0.0174	0.0199	CbGeAlD
Sirolimus—MTOR—spinal cord—Behcet's disease	0.0173	0.0197	CbGeAlD
Sirolimus—SLC47A1—mammalian vulva—Behcet's disease	0.0166	0.019	CbGeAlD
Sirolimus—FKBP1A—midbrain—Behcet's disease	0.0159	0.0182	CbGeAlD
Sirolimus—FKBP1A—spinal cord—Behcet's disease	0.0155	0.0178	CbGeAlD
Sirolimus—SLC47A1—medulla oblongata—Behcet's disease	0.015	0.0171	CbGeAlD
Sirolimus—MTOR—nervous system—Behcet's disease	0.0145	0.0166	CbGeAlD
Sirolimus—MTOR—central nervous system—Behcet's disease	0.014	0.016	CbGeAlD
Sirolimus—SLC47A1—spinal cord—Behcet's disease	0.0133	0.0153	CbGeAlD
Sirolimus—FKBP1A—nervous system—Behcet's disease	0.0131	0.015	CbGeAlD
Sirolimus—FKBP1A—central nervous system—Behcet's disease	0.0126	0.0144	CbGeAlD
Sirolimus—SLC47A1—nervous system—Behcet's disease	0.0112	0.0129	CbGeAlD
Sirolimus—MTOR—brain—Behcet's disease	0.0111	0.0127	CbGeAlD
Sirolimus—SLC47A1—central nervous system—Behcet's disease	0.0108	0.0124	CbGeAlD
Sirolimus—ABCB1—blood vessel—Behcet's disease	0.0106	0.0121	CbGeAlD
Sirolimus—FKBP1A—brain—Behcet's disease	0.00999	0.0114	CbGeAlD
Sirolimus—SLC47A1—brain—Behcet's disease	0.00859	0.00983	CbGeAlD
Sirolimus—EIF4E—Interferon type I signaling pathways—STAT4—Behcet's disease	0.00846	0.0672	CbGpPWpGaD
Sirolimus—ABCB1—retina—Behcet's disease	0.00557	0.00637	CbGeAlD
Sirolimus—ABCB1—mammalian vulva—Behcet's disease	0.00446	0.0051	CbGeAlD
Sirolimus—CYP3A4—nervous system—Behcet's disease	0.00427	0.00489	CbGeAlD
Sirolimus—CYP3A4—central nervous system—Behcet's disease	0.00411	0.00471	CbGeAlD
Sirolimus—ABCB1—Allograft Rejection—MICA—Behcet's disease	0.00406	0.0322	CbGpPWpGaD
Sirolimus—ABCB1—medulla oblongata—Behcet's disease	0.00402	0.00461	CbGeAlD
Sirolimus—MTOR—TSLP Signaling Pathway—STAT4—Behcet's disease	0.0039	0.031	CbGpPWpGaD
Sirolimus—FGF2—Angiogenesis—NOS3—Behcet's disease	0.00371	0.0295	CbGpPWpGaD
Sirolimus—ABCB1—midbrain—Behcet's disease	0.00368	0.00421	CbGeAlD
Sirolimus—ABCB1—spinal cord—Behcet's disease	0.00359	0.00411	CbGeAlD
Sirolimus—MTOR—Interferon type I signaling pathways—STAT4—Behcet's disease	0.00349	0.0277	CbGpPWpGaD
Sirolimus—MTOR—IL12-mediated signaling events—STAT4—Behcet's disease	0.00321	0.0255	CbGpPWpGaD
Sirolimus—ABCB1—nervous system—Behcet's disease	0.00302	0.00346	CbGeAlD
Sirolimus—ABCB1—central nervous system—Behcet's disease	0.00291	0.00333	CbGeAlD
Sirolimus—EIF4E—Leptin signaling pathway—NOS3—Behcet's disease	0.00269	0.0213	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—SERPINE1—Behcet's disease	0.00268	0.0213	CbGpPWpGaD
Sirolimus—MTOR—Costimulation by the CD28 family—CTLA4—Behcet's disease	0.0025	0.0198	CbGpPWpGaD
Sirolimus—MTOR—VEGFR2 mediated vascular permeability—NOS3—Behcet's disease	0.00244	0.0193	CbGpPWpGaD
Sirolimus—ABCB1—brain—Behcet's disease	0.00231	0.00264	CbGeAlD
Sirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SERPINE1—Behcet's disease	0.00218	0.0173	CbGpPWpGaD
Sirolimus—EIF4E—Interferon Signaling—HLA-B—Behcet's disease	0.00216	0.0172	CbGpPWpGaD
Sirolimus—MTOR—IL4-mediated signaling events—IL10—Behcet's disease	0.00209	0.0166	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.00206	0.0164	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ITGB2—Behcet's disease	0.00183	0.0145	CbGpPWpGaD
Sirolimus—MTOR—Type II diabetes mellitus—TNF—Behcet's disease	0.00182	0.0145	CbGpPWpGaD
Sirolimus—MTOR—RANKL/RANK Signaling Pathway—ICAM1—Behcet's disease	0.00178	0.0141	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.00178	0.0141	CbGpPWpGaD
Sirolimus—EIF4E—Interferon Signaling—ICAM1—Behcet's disease	0.00176	0.0139	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—ICAM1—Behcet's disease	0.00172	0.0136	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ITGAL—Behcet's disease	0.00165	0.0131	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—Behcet's disease	0.00158	0.0125	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—MEFV—Behcet's disease	0.00156	0.0124	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—MEFV—Behcet's disease	0.00149	0.0118	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.00144	0.0115	CbGpPWpGaD
Sirolimus—MTOR—TSLP Signaling Pathway—CXCL8—Behcet's disease	0.00143	0.0113	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—ERAP1—Behcet's disease	0.00139	0.011	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—SERPINE1—Behcet's disease	0.0013	0.0103	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—TNF—Behcet's disease	0.00127	0.0101	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—ERAP1—Behcet's disease	0.00127	0.0101	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—CXCL8—Behcet's disease	0.00122	0.00965	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.00118	0.00937	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.00117	0.00931	CbGpPWpGaD
Sirolimus—FGF2—DAP12 interactions—HLA-B—Behcet's disease	0.00116	0.0092	CbGpPWpGaD
Sirolimus—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.00113	0.00898	CbGpPWpGaD
Sirolimus—MTOR—Leptin signaling pathway—NOS3—Behcet's disease	0.00111	0.00879	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—MEFV—Behcet's disease	0.0011	0.00876	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—ITGB2—Behcet's disease	0.00103	0.00815	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—ITGB2—Behcet's disease	0.000981	0.00778	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	0.000954	0.00757	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ERAP1—Behcet's disease	0.000945	0.0075	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—ITGB2—Behcet's disease	0.000942	0.00747	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—ITGAL—Behcet's disease	0.000927	0.00735	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—SERPINE1—Behcet's disease	0.000886	0.00703	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.000877	0.00696	CbGpPWpGaD
Sirolimus—FGF2—Immune System—MEFV—Behcet's disease	0.000866	0.00687	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—HLA-B—Behcet's disease	0.00086	0.00682	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—ITGAL—Behcet's disease	0.000849	0.00674	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—TNF—Behcet's disease	0.000846	0.00672	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.000842	0.00668	CbGpPWpGaD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000835	0.00662	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—NOS3—Behcet's disease	0.000834	0.00661	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—NOS3—Behcet's disease	0.000787	0.00624	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ERAP1—Behcet's disease	0.000772	0.00613	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—Behcet's disease	0.000751	0.00596	CbGpPWpGaD
Sirolimus—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.000746	0.00592	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.000742	0.00589	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—ITGB2—Behcet's disease	0.000728	0.00577	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.000706	0.0056	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ITGB2—Behcet's disease	0.000699	0.00554	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CCR1—Behcet's disease	0.000698	0.00554	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CAT—Behcet's disease	0.000695	0.00552	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ICAM1—Behcet's disease	0.000684	0.00543	CbGpPWpGaD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00066	0.00524	CbGpPWpGaD
Sirolimus—MTOR—Immune System—MEFV—Behcet's disease	0.000643	0.0051	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CTLA4—Behcet's disease	0.000638	0.00506	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ITGAL—Behcet's disease	0.00063	0.005	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.000625	0.00496	CbGpPWpGaD
Sirolimus—MTOR—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.000598	0.00475	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CTLA4—Behcet's disease	0.000585	0.00464	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000576	0.00457	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ERAP1—Behcet's disease	0.000573	0.00455	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—SERPINE1—Behcet's disease	0.000571	0.00453	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ITGB2—Behcet's disease	0.000571	0.00453	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.000553	0.00439	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ITGAL—Behcet's disease	0.000515	0.00409	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCR1—Behcet's disease	0.000512	0.00406	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—HLA-B—Behcet's disease	0.000472	0.00374	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—HLA-B—Behcet's disease	0.00045	0.00357	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000436	0.00346	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CTLA4—Behcet's disease	0.000434	0.00344	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—HLA-B—Behcet's disease	0.000432	0.00343	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ITGB2—Behcet's disease	0.000424	0.00336	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CXCL8—Behcet's disease	0.000407	0.00323	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000406	0.00322	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR1—Behcet's disease	0.000388	0.00308	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—ICAM1—Behcet's disease	0.000383	0.00304	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ITGAL—Behcet's disease	0.000382	0.00303	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CXCL8—Behcet's disease	0.000359	0.00285	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CTLA4—Behcet's disease	0.000355	0.00281	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—ICAM1—Behcet's disease	0.000351	0.00279	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—APOB—Behcet's disease	0.000345	0.00274	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—HLA-B—Behcet's disease	0.000334	0.00265	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—APOB—Behcet's disease	0.00033	0.00262	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—HLA-B—Behcet's disease	0.000321	0.00255	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—SERPINE1—Behcet's disease	0.000318	0.00253	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000314	0.00249	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000299	0.00237	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR1—Behcet's disease	0.000288	0.00229	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000282	0.00224	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—APOA1—Behcet's disease	0.000273	0.00217	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTLA4—Behcet's disease	0.000263	0.00209	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HLA-B—Behcet's disease	0.000262	0.00208	CbGpPWpGaD
Sirolimus—FGF2—Disease—APOB—Behcet's disease	0.000262	0.00208	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—APOA1—Behcet's disease	0.000261	0.00207	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ICAM1—Behcet's disease	0.000261	0.00207	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000248	0.00197	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—APOB—Behcet's disease	0.000242	0.00192	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000236	0.00187	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—SERPINE1—Behcet's disease	0.000217	0.00172	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ICAM1—Behcet's disease	0.000213	0.00169	CbGpPWpGaD
Sirolimus—FGF2—Disease—APOA1—Behcet's disease	0.000207	0.00164	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS3—Behcet's disease	0.000207	0.00164	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SERPINE1—Behcet's disease	0.000207	0.00164	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—Behcet's disease	0.000204	0.00162	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NOS3—Behcet's disease	0.000198	0.00157	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-B—Behcet's disease	0.000195	0.00154	CbGpPWpGaD
Sirolimus—MTOR—Disease—APOB—Behcet's disease	0.000194	0.00154	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—APOA1—Behcet's disease	0.000191	0.00152	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOB—Behcet's disease	0.000183	0.00145	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—Behcet's disease	0.000175	0.00139	CbGpPWpGaD
Sirolimus—FGF2—Disease—SERPINE1—Behcet's disease	0.000164	0.0013	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ICAM1—Behcet's disease	0.000158	0.00125	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—Behcet's disease	0.000157	0.00125	CbGpPWpGaD
Sirolimus—MTOR—Disease—APOA1—Behcet's disease	0.000154	0.00122	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SERPINE1—Behcet's disease	0.000152	0.0012	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000149	0.00119	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—Behcet's disease	0.000145	0.00115	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOA1—Behcet's disease	0.000145	0.00115	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CAT—Behcet's disease	0.000144	0.00114	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOB—Behcet's disease	0.00014	0.00111	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000139	0.00111	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOB—Behcet's disease	0.000136	0.00108	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CAT—Behcet's disease	0.000132	0.00105	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—Behcet's disease	0.000129	0.00102	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOB—Behcet's disease	0.000128	0.00102	CbGpPWpGaD
Sirolimus—MTOR—Disease—SERPINE1—Behcet's disease	0.000122	0.000968	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000118	0.000938	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—Behcet's disease	0.000116	0.000924	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SERPINE1—Behcet's disease	0.000115	0.000913	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOA1—Behcet's disease	0.000111	0.000878	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—Behcet's disease	0.00011	0.000872	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOA1—Behcet's disease	0.000108	0.000854	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOA1—Behcet's disease	0.000102	0.000806	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—Behcet's disease	9.75e-05	0.000773	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CAT—Behcet's disease	9.56e-05	0.000758	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOB—Behcet's disease	9.28e-05	0.000736	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SERPINE1—Behcet's disease	8.54e-05	0.000678	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—Behcet's disease	8.39e-05	0.000665	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—Behcet's disease	8.15e-05	0.000647	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—Behcet's disease	7.7e-05	0.000611	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOA1—Behcet's disease	7.34e-05	0.000583	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—Behcet's disease	7.23e-05	0.000574	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CAT—Behcet's disease	7.21e-05	0.000572	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOB—Behcet's disease	7e-05	0.000556	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—Behcet's disease	5.56e-05	0.000441	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOA1—Behcet's disease	5.54e-05	0.00044	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CAT—Behcet's disease	4.44e-05	0.000353	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOB—Behcet's disease	4.31e-05	0.000342	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—Behcet's disease	4.2e-05	0.000333	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOA1—Behcet's disease	3.41e-05	0.000271	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—Behcet's disease	2.59e-05	0.000205	CbGpPWpGaD
